Goldman-Backed Biotech Attovia Seeks $212.5 Million in US IPO


Alamar, a maker of medical devices focused on studying proteins and disease detection, set up Attovia as a separate company in 2023, and remains an investor. Alamar raised $219.9 million in an IPO, and the shares have climbed 43% since its debut in April.



Source link

  • Related Posts

    US Launches New Strikes Against Iran as War Escalates Again

    The US and Iran had paused an exchange of strikes at the end of last week in an effort to further diplomatic talks and bring an end to the months-long…

    Best Deodorants for Kids in 2026, According to Dermatologists

    We don’t always have the answers, but we have some people on speed dial who do — which is why we present to you our series FYI where we have…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Musk went to “war,” sought jail time for X ad boycotts—but case ends with a whimper

    Musk went to “war,” sought jail time for X ad boycotts—but case ends with a whimper

    Capcom Says The Likelihood Of A Pragmata Sequel Is High

    Capcom Says The Likelihood Of A Pragmata Sequel Is High

    Why Is Qantas The Only Airline Flying Nonstop From Australia To Continental Europe?

    Why Is Qantas The Only Airline Flying Nonstop From Australia To Continental Europe?

    Trump considering AI controls after OpenAI hacking incidents

    Trump considering AI controls after OpenAI hacking incidents

    Summer of storms keeps Edmonton-area festival organizers on their toes

    Summer of storms keeps Edmonton-area festival organizers on their toes

    The 15 Best Pool Accessories to Upgrade Your Summer (2026)

    The 15 Best Pool Accessories to Upgrade Your Summer (2026)